These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8568627)

  • 1. Synthesis and antiplatelet effects of omega-aminoalkoxylxanthones.
    Lin CN; Liou SS; Lai SC; Lin HC; Ko FN; Liu HW; Teng CM
    J Pharm Pharmacol; 1995 Jul; 47(7):588-94. PubMed ID: 8568627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-pyrone compounds. II: Synthesis and antiplatelet effects of tetraoxygenated xanthones.
    Lin CN; Liou SS; Ko FN; Teng CM
    J Pharm Sci; 1992 Nov; 81(11):1109-12. PubMed ID: 1447715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the synthesis of some xanthonoid derivatives possessing antiplatelet effects.
    Lin CN; Fang SC; Lin HC; Ko FN; Shieh BJ; Liu HW; Teng CM
    J Pharm Pharmacol; 1994 Nov; 46(11):917-21. PubMed ID: 7897599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
    Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
    Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gamma-Pyrone compounds. 5. Synthesis and antiplatelet effects of xanthonoxypropanolamines and related compounds.
    Liou SS; Teng CM; Ko FN; Lin CN
    J Pharm Sci; 1994 Mar; 83(3):391-5. PubMed ID: 8207688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antithrombotic effect of xanthone derivatives.
    Lin CN; Hsieh HK; Liou SJ; Ko HH; Lin HC; Chung MI; Ko FN; Liu HW; Teng CM
    J Pharm Pharmacol; 1996 Sep; 48(9):887-90. PubMed ID: 8910846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antiplatelet and vasorelaxing effects of monooxygenated flavones and flavonoxypropanolamines.
    Chung MI; Han FW; Lin HC; Liou SS; Huang PL; Ko HH; Chang YL; Kang JJ; Teng CM; Lin CN
    J Pharm Pharmacol; 2001 Dec; 53(12):1601-9. PubMed ID: 11804390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gamma-Pyrone compounds. IV: Synthesis and antiplatelet effects of mono- and dioxygenated xanthones and xanthonoxypropanolamine.
    Lin CN; Liou SS; Ko FN; Teng CM
    J Pharm Sci; 1993 Jan; 82(1):11-6. PubMed ID: 8429484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of thromboxane formation as the antiplatelet mechanism of 3,4-dihydroxyxanthone and quercetin pentaacetate.
    Lin HC; Liu HW; Lin CN; Teng CM
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Oct; 7(10):505-12. PubMed ID: 1811069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol.
    Lin CH; Kuo YH; Lin YL; Teng CM
    J Pharm Pharmacol; 1994 Jan; 46(1):54-7. PubMed ID: 8201527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
    Liao CH; Ko FN; Wu CL; Teng CM
    J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents.
    Ko TC; Hour MJ; Lien JC; Teng CM; Lee KH; Kuo SC; Huang LJ
    Bioorg Med Chem Lett; 2001 Feb; 11(3):279-82. PubMed ID: 11212091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2',5'-Dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor.
    Lin CN; Lee TH; Hsu MF; Wang JP; Ko FN; Teng CM
    J Pharm Pharmacol; 1997 May; 49(5):530-6. PubMed ID: 9178190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets.
    Lim H; Kubota K; Kobayashi A; Seki T; Ariga T
    Biosci Biotechnol Biochem; 1999 Feb; 63(2):298-301. PubMed ID: 10192909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antiplatelet naphthalene from Rhamnus nakaharai.
    Lin CN; Lu CM; Lin HC; Ko FN; Teng CM
    J Nat Prod; 1995 Dec; 58(12):1934-40. PubMed ID: 8691213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet activity of some prenylflavonoids.
    Lin CN; Shieh WL; Ko FN; Teng CM
    Biochem Pharmacol; 1993 Jan; 45(2):509-12. PubMed ID: 8435100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.